JENNIFER SMITH: Open Payments
NPI 1699184895 · STATESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 29 payments from 13 companies in 2025. Trend: 2023 $674 · 2024 $1,013 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $84 |
| Lilly USA, LLC | 4 | $75 |
| Lundbeck LLC | 3 | $63 |
| Exact Sciences Corporation | 3 | $48 |
| Amgen Inc. | 3 | $46 |
| Novo Nordisk Inc | 3 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Abbott Laboratories | 1 | $16 |
Products named: REXULTI, MOUNJARO, VRAYLAR, Rybelsus, JARDIANCE, EVENITY, The Cologuard Plus Collection Kit, QULIPTA.
Industry payments across GA — which companies pay providers there.
